According to Benzinga Pro data, during Q2, Independence Contract (NYSE:ICD) posted sales of $42.31 million. Earnings were up 95.25%, but Independence Contract still reported an overall loss of $2.79 million.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Independence Contract (NYSE:ICD) will host a conference call at 12:00 PM ET on May 5, 2022, to discuss Q1 2022 earnings results.
How to Attend Independence Contract (ICD) Conference Call
Follow this link to access the live webcast.
Gainers
Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit.